Sitemap
March 24, 2024 Articles
Filter by Available Specialty
- Cancer during pregnancy: Optimize treatment, minimize risks, ‘meet patients where they are’
- Heron Therapeutics reports fourth-quarter, full-year 2023 financial results
- Jasper Therapeutics doses first patient in chronic inducible urticaria study
- VIDEO: New treatment options on the horizon for patients with presbyopia